Mosaic Diagnostics’ Post

Charles River has a long and proud history of investing in and embracing the components of the 3Rs principle (Replacement, Reduction, and Refinement). To further advance science and to continue to lead the industry in identifying technologies and supporting efforts by global regulatory bodies, Charles River added fourth R as Responsibility. This article presents Charles River’s commitment to Replacement and Responsibility to develop a robust, animal-free recombinant cascade reagent (rCR), Endosafe® Trillium™. I take pride to help bring this product to market and share that a methodical Stage-Gate process allowed for the development of rCR with the utmost quality, scientific rigor, and data driven decisions resulting in robust, reliable, sensitive, recombinant BET that provides the same confidence, flexibility, ease of use and ensures patient safety as traditional LAL products. Please read the full article https://lnkd.in/dxXBxYRR

“Which carries more risk: participation or avoidance?” – the big question many in the corporate world face when it comes to social media.   For a highly regulated industry like #pharma, avoidance is often the easier, safer choice – but is it the most effective? Not necessarily, as convincingly articulated by Roger Christie, keynote speaker of the MedNews Aust/NZ event, “Pharma reputation: Building trust in the digital age”.   Great insights and discussions were shared on this and other themes surrounding reputation within the pharma industry, with one thought resonating with everyone in the room: in order to be trusted, you have to be liked; in order to be liked, you have to be known.   As panellist John Morton argued, it all comes down to "what’s your story, who are you trying to communicate with and for what purpose?" These are very useful parameters for the pharma industry to take stock of and drive more proactive communication on how it contributes to health, wellbeing and productivity within our societies today.

Human #biospecimens are hard to collect, with many governmental bodies and medical professional societies establishing regulations and accreditation programs to ensure they are collected ethically and according to established best practices. The blog 'Understanding Regulatory Guidelines for Sourcing Human Biospecimens', lays out the foundation for understanding these regulations and making sure your provider is compliant. Read now: https://hubs.ly/Q028G72K0

Efficient triage in the emergency department is simplified with suPARnostic® in five key steps. ⬇️ Implementing suPAR into the triage process is simple: Compatibility: suPARnostic® products are approved for all major chemical analyzers Integration: Seamless integration into existing hospital laboratory workflows with sample compatibility Rapid Results: Receive suPAR results in less than 20 minutes Equipped with this information, doctors can make informed decisions: 🟢 Below 4ng/mL: Supports discharge. 🔴 Above 6ng/mL: Supports admission. Learn more about how suPAR enhances triage efficiency: https://lnkd.in/dTWP4UUy #suPAR #TriageExcellence

With ever changing global regulatory regulations and requirements, rest assured that BioIVT has you covered.

How Pharm-D started: It all began with the passion and heart to help patients in need, no matter how rare, uncommon or niche a condition or disease can be. We ardently believe that health is a universal right, and our commitment is to make it inclusive for everyone. Simply because, every life matters. Pharm-D is a proud member of the Pharm-D Health Science group of companies (previously known as Bioscenergy International Sdn Bhd). #pharmdcompany #pharmdhealthscience #healthequality #healthinclusivity #healthforall #healthforallwithscience #nichemedicine #namedpatientprogram #emergencymedicine

🌐We are Oxygen Life Sciences navigating change in regulators and regulations by International and national health authorities. ⬇️We play a critical role but one that may need to evolve to remain relevant and effective in the face of technology-induced change. ⬇️Wexamine the challenges that regulators face in our rapidly changing world—from keeping up with technical and business model innovations and the growth. ⬇️We then identify opportunities for leaders of regulatory agencies to navigate today’s challenging landscape and prepare for the future—both in the way they make rules and the way they enforce them. ⬇️Regulators are on the front lines of nearly every controversy resulting from a new technology—either being told to get out of the way or being called upon for solutions when incidents arise. ⬇️In a fast-moving and increasingly complex world, regulators are finding it harder and harder to balance the need to protect citizens and fair markets with the need to avoid impeding innovation. 📩Contact us today to discuss how Oxygen Life Sciences can create a robust Regulatory submission and approval plan forward till next level. Email: [email protected] Contact Number: +44 7543 519010

Great Webinar On Emerging The Trends in Pharmacovigillance And ClinicalTrials #AmanPharmacyCollege

Ozempic, a new weight-loss drug, is sparking debates both within and outside of body-positive and weight-related communities. While some see it as a life-changing solution, others perceive it as fueling judgment and creating a divide among groups advocating body acceptance. Furthermore, weight-loss businesses and health companies are adjusting strategies based on the drug's potential. The vast differences in reactions show how this revolutionary drug is altering personal relationships, societal judgments, and industry dynamics.</div><div class="read-more"><a href="" class="more-link">Continue reading</a>https://lnkd.in/gtwg3agE

This Commentary by Health and Environmental Sciences Institute (HESI) Director, Dr. Syril Pettit, DrPH, asserts that the challenges of realizing the systems-level changes needed to catalyze the broad-scale adoption and use of New Approach Methodologies #NAMs may be less unique than perceived to date, and points to specific opportunities to learn from decades of experience from the Quality Improvement #QI movement in the #publichealth and #healthcare arenas. Read the full article at the link below. https://lnkd.in/gBg6BW8g